Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2025) 110 P967 | DOI: 10.1530/endoabs.110.P967

ECEESPE2025 Poster Presentations Pituitary, Neuroendocrinology and Puberty (162 abstracts)

Clinical manifestations and health care utilisation in septo-optic dysplasia, with particular focus on overweight and obesity

David Cullingford 1,2,3 , Mary Abraham 1,2,3 , Aris Siafarikas 1,2,3 , Marie Blackmore 2 , Jenny Downs 2,4 & Catherine Choong 1,2,3


1Perth Children’s Hospital, Endocrinology and Diabetes, Perth, Australia; 2The Kids Research Institute Australia, The Centre for Child Health Research, Perth, Australia; 3University of Western Australia, Perth, Australia; 4Curtin University, Perth, Australia


JOINT1898

Purpose: To describe the clinical phenotype, and burden of health care utilisation in children with septo-optic dysplasia (SOD).

Methods: A single-centre retrospective chart review of patients with SOD seen at a single tertiary centre between 2003 and 2023 was performed. Data were obtained from the clinical record, electronic patient administration system and medical imaging reports, with comparison to local paediatric population data reported by the Australian Bureau of Statistics. An elevated BMI was defined as >1 SDS, and obesity as >1.65. Health care utilisation was assessed by reporting the number of medical and allied health specialties involved, and annual frequency of inpatient, outpatient and emergency department presentations.

Results: Eighty-one children were enrolled (median age 11.6 years, 32 females), 62/81 with bilateral optic nerve hypoplasia. Of 71 children with pituitary and anthropometric data, 41 had hypopituitarism and 31 had an elevated BMI. 37/51 children with pituitary structural defects had hypopituitarism compared to 3/20 without (P < 0.001). Children with SOD had higher rates of elevated BMI than the general population (42.5% vs 26.2%, P = 0.001) and obesity was more prevalent in those with (33%) and without (24.1%) hormonal deficiencies than the general population (6%, P < 0.001). Children with BMI elevation had greater median height SDS scores than those with a normal BMI (0.45 vs -0.78, P = 0.001). This was seen in those with and without hypopituitarism, but not demonstrated in those with GH deficiency (P = 0.103). Children with hypopituitarism who had an elevated BMI, developed this at a younger age than those without hypopituitarism (median 2.4 years [interquartile range 2.0-5.0] vs 5.9 years [4.1-10.5], P = 0.038). 12/31 with elevated BMI and 6/19 with obesity met criteria for these at 2 years of age. Approximately two thirds (55/81) were diagnosed in infancy. The median age at diagnosis of first endocrinopathy was 0.6 years (0.2-3.8). The median number of medical and allied health specialties seen was 9, with 70/81 seeing 5 or more specialties. Children with hypopituitarism had more frequent emergency department presentation, inpatient admission, and outpatient appointments than those without pituitary dysfunction.

Main Conclusions: SOD is a complex multisystem disorder. Regarding BMI elevation, although those with hormonal deficiencies have greater prevalence and develop BMI elevation earlier, prevalence is higher in children with SOD irrespective of pituitary function. The high rates of healthcare attendance in multiple specialties support the importance of treatment in a multidisciplinary clinic to ensure comprehensive care and minimise burden on families.

Volume 110

Joint Congress of the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) 2025: Connecting Endocrinology Across the Life Course

European Society of Endocrinology 
European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches